Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Leukemia × eryaspase × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1

Interventions

Cyclophosphamide 106 fludarabine phosphate 82 Cytarabine 77 fludarabine 63 Rituximab 63 Methotrexate 58 Busulfan 48 Whole-Body Irradiation 44 Filgrastim 39 Tacrolimus 36 Mycophenolic Acid 36 Antilymphocyte Serum 35 Etoposide 34 Melphalan 31 Vincristine 29 Azacitidine 29 Peripheral Blood Stem Cell Transplantation 27 Alemtuzumab 27 Granulocyte Colony-Stimulating Factor 26 Clofarabine 26 Dexamethasone 25 Cyclosporine 24 thymoglobulin 23 Imatinib Mesylate 23 Doxorubicin 20 Lenalidomide 19 Stem Cell Transplantation 18 Methylprednisolone 18 Decitabine 17 sargramostim 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01810705 2022-02-21

ENFORCE

ERYtech Pharma

Phase 2 Completed

123 enrolled 8 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡